Professor Souied is a renowned ophthalmologist and international expert in AMD (Age-related Macular Degeneration)  He will guide the scientific focus of SeaBeLife’s ophthalmological program, the only ...

Moby Strategic Pillars and Performance Drivers. Management characterizes 2025 as a foundational year of disciplined e ...

The study assessed changes in retinal structure and visual function before and after intravitreal pegcetacoplan initiation. A ...

Company will debut five-year results from GALE study showing meaningful impact of early and continuous treatment with SYFOVRE® (pegcetacoplan injection) WALTHAM, Mass., Feb. 19, 2026 (GLOBE NEWSWIRE) ...

Steffen Schmitz-Valckenberg, MD, discusses how optical coherence tomography-based models may enable rapid, noninvasive assessment of functional loss in GA at Angiogenesis 2026.

Gelmedix Inc. has completed a $13 million seed financing to support progression of the company’s lead program, GMX-101, a retinal pigment epithelial (RPE) cell therapy to treat late-stage geographic ...

At Envision Summit 2026, the “Fast and Fundus” retina panel delivered rapid-fire case discussions grounded in practical ...

Industry veteran brings global regulatory expertise to support development of innovative optogenetic gene therapies—BERKELEY, Calif.--(BUSINESS WIRE)--Ray Therapeutics, a clinical-stage biotechnology ...

GelMEDIX, Inc., a biotechnology company developing regenerative therapies to restore vision, announced today the completion of a $13 million seed financing led by Safar Partners, with participation ...

-- The unmet need and current treatment landscape for GA -- The mechanism of disease and role of C1q -- Vonaprument, Annexon's neuroprotective C1q inhibitor with the potential to be the first targeted ...

COLUMBUS – Prevent Blindness Ohio is declaring February as Age-related Macular Degeneration and Low Vision Month in an effort to provide education and various expert-approved resources to the public ...